These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8799381)

  • 1. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
    Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
    Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
    Mazumdar S; Das KM
    Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
    Bernstein CN; Robert ME; Eysselein VE
    Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis.
    Jönsson M; Norrgård O; Hansson M; Forsgren S
    Ann N Y Acad Sci; 2007 Jun; 1107():280-9. PubMed ID: 17804556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
    Yantiss RK; Das KM; Farraye FA; Odze RD
    Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC).
    Gionchetti P; Campieri M; Belluzzi A; Tampieri M; Bertinelli E; Brignola C; Ferretti M; Boni P; Iannone P; Miglioli M
    Agents Actions; 1992; Spec No():C50-2. PubMed ID: 1442335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
    Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
    Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal and plasma prostaglandin E2 in ulcerative colitis.
    Wiercinska-Drapalo A; Flisiak R; Prokopowicz D
    Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.
    Keshavarzian A; Fusunyan RD; Jacyno M; Winship D; MacDermott RP; Sanderson IR
    Am J Gastroenterol; 1999 Mar; 94(3):704-12. PubMed ID: 10086655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic vasoactive intestinal polypeptide in ulcerative colitis.
    Surrenti C; Renzi D; Garcea MR; Surrenti E; Salvadori G
    J Physiol Paris; 1993; 87(5):307-11. PubMed ID: 8298608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization of intercellular adhesion molecule-1 in colonic mucosa in ulcerative colitis.
    Vainer B; Sørensen S; Nielsen OH; Horn T
    Ultrastruct Pathol; 2002; 26(2):113-21. PubMed ID: 12036091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
    Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
    Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon.
    Jönsson M; Norrgård O; Forsgren S
    Dig Dis Sci; 2012 Feb; 57(2):303-10. PubMed ID: 22143367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confocal endomicroscopy in patients with ulcerative colitis.
    Watanabe O; Ando T; Maeda O; Hasegawa M; Ishikawa D; Ishiguro K; Ohmiya N; Niwa Y; Goto H
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S286-90. PubMed ID: 19120913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical study of HLA-DR expression in superficial epithelium and in lamina propria of colonic mucosa in children with Crohn's disease and nonspecific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(2):143-51. PubMed ID: 9814381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
    Strugala V; Dettmar PW; Pearson JP
    Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.